TrialJectory
Avital Gaziel, currently the Co-founder and Chief Science Officer at Leal Health, has a strong background in scientific research and medical communications. With experience in roles such as Associate Medical Director and Biomedical Writer at Grey Healthcare Group, Avital has contributed to various scientific programs, mainly in the field of oncology. With a Ph.D. in Oncology and Cancer Biology from New York University, Avital has published original research in prestigious journals and collaborated closely with scientists from different fields. Prior to their current role, Avital held positions at A. Gaziel Medical Communications, NYU School of Medicine, and Tel Aviv University.
This person is not in any offices
TrialJectory
1 followers
TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. We use artificial intelligence (AI) to empower patients to own their cancer journey and analyze our global patient community's real-world data to empower cancer patients to make the most informed decisions about their care.